copper peptide ghk-cu clinical trial injection (GHK-Cu): Clinical Uses, Stability & Compounding Tips GHK-Cu 50mg Copper Peptide, Packaging

11 , eaaw8283 (2019)

This combination may be studied for traumatic brain injury, stroke, and neurodegenerative diseases like ALS and Alzheimers

Results We evidenced that the stable gastric pentadecapeptide BPC 157 recovers myotendinous junction, likely with the functional recovery, muscle size recovery, and counteraction of the oxidative stress, and particular effect on COX 2 , nNOS , iNOS , eNOS mRNA levels in the dissected myotendinous junction (Figure 1, Figure 2, Figure 3, Figure 4, Figure 5, Figure 6, Figure 7, Figure 8, Figure 9, Figure 10, Figure 11, Figure 12, Figure 13,Figure 14 and Figure 15)

add Z29.11 (encounter for prophylactic RhoGAM) if applicable